As of November 2024, Chemomab Therapeutics has a market cap of $19.70M. This makes Chemomab Therapeutics the world's 30152th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $6.72M | 17.16% |
2023 | $5.74M | -84.06% |
2022 | $36.01M | -53.62% |
2021 | $77.66M | -75.07% |
2020 | $311.52M | 23.57% |
2019 | $252.10M | - |